Test tubes at a federal lab studying CAR-T. Photo: Saul Loeb/AFP via Getty Images
Medicare is proposing to cover the new cancer treatment, known as CAR-T, that helps patients fight the disease with their own immune cells.
Yes, but: This doesn't address how much Medicare will pay. Cancer hospitals are lobbying for higher payments after Medicare said earlier this year it would pay $223,000 for the average inpatient treatment.